Delivery Order SPE2DB22D1106-SPE2DB24FDXE5
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The contract has a potential value of $2,770.74 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) the company...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Humira Pen 40 mg/0.8 ml pharmaceutical products. The contract has a potential value of $4,617.90 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with any set-aside program. Amerisourcebergen Drug Corp...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical product. The $4,455.88 order has a completion date of February 28, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $4,430.58 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is issued under an Indefinite Delivery Contract (IDC) that the company holds with DLA Troop Support Medical, with a potential value of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceuticals. The $2,770.74 award has a performance period through February 20, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger $999,999,999.00 indefinite delivery contract (IDC)...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $15,079.74 to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA PEN 40 MG/0.8 MLS pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corporation. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) PEN 80 MG/0.8 MLS pharmaceutical products. The contract has a potential value of $4,409.34 and a completion date of March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order is issued under an indefinite delivery contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceuticals. The contract, valued at $6,641.07, has a completion date of February 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is not subject to any set-aside designations for this award. The contract is part of Amerisourcebergen...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $12,136.56 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HUMIRA PEN 40 MG/0.8 MLS. The order has a completion date of March 6, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense, through various contracts. This...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide HUMIRA (CF) PEN 40 MG/0.4 MLS pharmaceutical products. The delivery order has a ceiling value of $7,103.91 and a period of performance through March 20, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) valued at up to...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDXE5Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The order has a potential value of $4,416.36 and a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and the parent company is Cencora, Inc., which does business as Amerisourcebergen. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 1/25/24 |